IA Blog: PERA Hearing Takeaways – Patent Eligibility Uncertainty is Undermining American Leadership
Seeing the headlines coming out of last week’s Senate Judiciary Committee hearing on patent eligibility law, you’d think this issue is about drug pricing. But you’d be wrong. The real issue is whether or not America will continue to be the global leader in technological innovation.
Here are the real headlines and takeaways that deserve attention:
1. Confusion and uncertainty around U.S. patent eligibility law is undermining American innovation.
A series of Supreme Court decisions in recent decades has left innovators, investors, and courts struggling to determine what inventions are eligible for patent protection. Federal Circuit judges and USPTO Directors have been calling on Congress for years to provide clarity. When inventors and businesses cannot predict whether breakthrough technologies will receive meaningful patent protection, they are less likely to invest in developing them.
2. U.S. leadership in AI is now also at stake.
In a new large-scale empirical study released just before the hearing, which was read into the record, researchers found that AI-related patents are significantly more likely to be invalidated than non-AI patents —and that disparity is driven primarily by problems with Section 101 patent eligibility law. At the very moment AI is becoming central to economic growth, military capability, and global competition, our patent system is making it harder to protect these critical technologies.
3. China is capitalizing on our uncertainty.
While the United States debates whether innovations in AI, advanced computing, software, biotechnology, and medical diagnostics qualify for patent protection, China and other competitors are moving aggressively to protect these same technologies. Former USPTO Director Andrei Iancu warned that America is creating a self-inflicted competitive disadvantage, one that threatens not only our innovation economy, but our national security.
The greatest threat to American innovation isn’t stronger competition from China – it’s uncertainty here at home.
Congress should pass PERA and restore the clear, predictable patent system that has long made America the world’s innovation leader.